Isolation of efficient antivirals: genetic suppressor elements against HIV-1. (Q30701530)

26 June 2017

Isolation of efficient antivirals: genetic suppressor elements against HIV-1. (English)

1 reference

26 June 2017

Dunn SJ

1

1 reference

26 June 2017

Park SW

2

1 reference

26 June 2017

Sharma V

3

1 reference

26 June 2017

Raghu G

4

1 reference

26 June 2017

Simone JM

5

1 reference

26 June 2017

Tavassoli R

6

1 reference

26 June 2017

Young LM

7

1 reference

26 June 2017

Ortega MA

8

1 reference

26 June 2017

Pan CH

9

1 reference

26 June 2017

Alegre GJ

10

1 reference

26 June 2017

Roninson IB

11

1 reference

26 June 2017

Lipkina G

12

1 reference

26 June 2017

Dayn A

13

1 reference

26 June 2017

Holzmayer TA

14

1 reference

26 June 2017

1 January 1999

1 reference

26 June 2017

1 reference

26 June 2017

6

1 reference

26 June 2017

130-137

1 reference

26 June 2017

1

1 reference

Isolation of dominant negative mutants and inhibitory antisense RNA sequences by expression selection of random DNA fragments

26 June 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300791

Isolation of genetic suppressor elements, inducing resistance to topoisomerase II-interactive cytotoxic drugs, from human topoisomerase II cDNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300791

Cloning mammalian genes by expression selection of genetic suppressor elements: association of kinesin with drug resistance and cell immortalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300791

Genetic selection of growth-inhibitory sequences in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300791

Use of genetic suppressor elements to dissect distinct biological effects of separate p53 domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300791

Suppression of the novel growth inhibitor p33ING1 promotes neoplastic transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300791

Identification of p53 genetic suppressor elements which confer resistance to cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300791

A functional peptide encoded in the Escherichia coli 23S rRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300791

Applying the PDR principle to AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300791

Gene therapy. Intracellular immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300791

Gene therapy for infectious diseases: the AIDS model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300791

Gene therapy for human immunodeficiency virus infection: genetic antiviral strategies and targets for intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300791

HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300791

Stable expression of transdominant Rev protein in human T cells inhibits human immunodeficiency virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300791

Inhibition of human immunodeficiency virus type 1 replication in human T cells by retroviral-mediated gene transfer of a dominant-negative Rev trans-activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300791

Nonviral and viral delivery of a human immunodeficiency virus protective gene into primary human T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300791

A transdominant tat mutant that inhibits tat-induced gene expression from the human immunodeficiency virus long terminal repeat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300791

Studies on the effect of the combined expression of anti-tat and anti-rev genes on HIV-1 replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300791

Inhibition of human immunodeficiency virus type-1 by retroviral vectors expressing antisense-TAR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300791

High transdominant RevM10 protein levels are required to inhibit HIV-1 replication in cell lines and primary T cells: implication for gene therapy of AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300791

Trans-activation of the human immunodeficiency virus long terminal repeat sequence by DNA viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300791

A molecular clone of HTLV-III with biological activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300791

Detection of intracellular HIV in lymphocytes by flow cytometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300791

Functional dissection of the HIV-1 Rev trans-activator—Derivation of a trans-dominant repressor of Rev function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300791

Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300791

inferred from DOI database lookup

7 January 2021

based on heuristic

Inhibition of human immunodeficiency virus type 1 in human T cells by a potent Rev response element decoy consisting of the 13-nucleotide minimal Rev-binding domain.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300791

inferred from DOI database lookup

7 January 2021

based on heuristic

Inhibition of human immunodeficiency virus type 1 replication is enhanced by a combination of transdominant Tat and Rev proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300791

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.GT.3300791

1 reference

26 June 2017

1 reference